Selkirk Copper Mines announced that its Minto Project in Yukon has been selected for the 2026 Canada Investment Summit Dealbook, highlighting it as a key investment opportunity. The project, a copper-gold-silver mine restart targeting production by mid-2028, is notable for majority ownership by the Selkirk First Nation. Inclusion in the Dealbook increases visibility among Canadian and global investors, supporting the Canadian government's goal to attract significant investment in critical minerals. The company and Selkirk First Nation emphasize sustainable mining practices and economic benefits for the local community as they advance toward project restart.
Selkirk Copper's Minto Project is highlighted in the 2026 Canada Investment Summit Dealbook. For readers following the Basic Materials sector, here is Pluang's market snapshot as of Sep 15, 2026 19:13 WIB: out of 32 priced US stocks, 12 rose and 18 fell. Notable prices include Newmont Corporation at USD 122.25, Air Products & Chemicals at USD 285.43, and Icl Group Ltd at USD 5.48.
NeOnc Technologies reported early clinical improvement in a critically ill three-year-old boy with an aggressive brain tumor treated with investigational intranasal NEO100 under compassionate use in Abu Dhabi. The child is now breathing independently...
TransUnion's Branded Call Display, a solution that helps consumers identify legitimate callers and avoid robocall fraud, has been named one of TIME's Best Inventions of 2026 in the Connectivity & Communication category. The technology displays a busi...
La Rosa Holdings Corp. will change its name to Stratum Holdings Corp. on October 19, 2026, reflecting its shift from real estate services to an AI infrastructure company specializing in GPU leasing and high-performance computing. The company recently...
ASUS has released the ProArt P16 and P14 laptops in Canada, powered by NVIDIA RTX Spark technology. These laptops feature up to 128GB of unified memory and advanced AI capabilities designed for creators, AI developers, and workflow builders, enabling...
OXB, a global cell and gene therapy CDMO, has appointed Dr Joachim Kreuzburg as an Independent Non-Executive Director effective November 23, 2026. Dr Kreuzburg brings over 20 years of leadership in life sciences, notably transforming Sartorius AG int...
